Abstract |
Our observations indicate that umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) have a strong migration capacity toward the human glioma cell line, U-87 MG, LN18, U138, and U251, when compared to several other cancer cell lines. In order to identify soluble factors that function to attract UCB-MSCs, we used cytokine antibody arrays to screen changed cytokines in conditioned media from U-87 MG cells. Among these, interleukin-8 (IL-8) and growth-related oncogene (GRO-alpha) enhanced UCB-MSC migration. Furthermore, antibodies treatment against the IL-8 receptors reduced these migration events and overexpression of IL-8 in cells with lower level of IL-8 such as A549 could induce UCB-MSC migration. Since we found that the capacity of UCB-MSC migration is much higher than that of bone marrow-derived MSCs (BM-MSCs) toward either U-87 MG cells or recombinant IL-8, we compared the levels of the IL-8 receptor, CXC chemokine receptor 1 (CXCR1) and CXCR2 between two kinds of MSCs by RT-PCR and immunostaining. Expression levels of two receptors were much higher in UCB-MSCs than in BM-MSCs. These data suggest that higher levels of two IL-8 receptors could influence downstream signaling events affecting superior UCB-MSC migration toward the glioma cells.
|
Authors | Dal-Soo Kim, Ji Hyun Kim, Jae Kwon Lee, Soo Jin Choi, Jae-Sung Kim, Sin-Soo Jeun, Wonil Oh, Yoon Sun Yang, Jong Wook Chang |
Journal | Stem cells and development
(Stem Cells Dev)
Vol. 18
Issue 3
Pg. 511-9
(Apr 2009)
ISSN: 1557-8534 [Electronic] United States |
PMID | 18624673
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Interleukin-8
- Receptors, CXCR
- Receptors, Interleukin-8
|
Topics |
- Cell Line, Tumor
- Cell Movement
(physiology)
- Cells, Cultured
- Fetal Blood
(cytology)
- Glioma
(metabolism, pathology)
- Humans
- Interleukin-8
(metabolism)
- Mesenchymal Stem Cells
(cytology, physiology)
- Receptors, CXCR
(genetics, metabolism)
- Receptors, Interleukin-8
(genetics, metabolism)
|